Evidence map›Paper›PMID 32054931›Full record

ArticleScientific reports2020

Radiogenomics predicts the expression of microRNA-1246 in the serum of esophageal cancer patients.

Isamu Hoshino, Hajime Yokota, Fumitaka Ishige, Yosuke Iwatate, Nobuyoshi Takeshita, Hiroki Nagase, Takashi Uno, Hisahiro Matsubara

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. The Oesophageal Cancer Multidisciplinary Team: Can Machine Learning Assist Decision-Making?Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. A deep survival interpretable radiomics model of hepatocellular carcinoma patients.Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) · 2021
    Article
  10. Development and Validation of aFrontiers in oncology · 2021
    Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Isamu Hoshino *Division of Gastroenterological Surgery, Chiba Cancer Center, Chiba, Japan. ihoshino@chiba-cc.jp.
Hajime Yokota *Department of Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Fumitaka IshigeDepartment of Hepatobiliary and Pancreatic Surgery, Chiba Cancer Center, Chiba, Japan.
Yosuke IwatateDepartment of Hepatobiliary and Pancreatic Surgery, Chiba Cancer Center, Chiba, Japan.
Nobuyoshi TakeshitaDivision of Surgical Technology, National Cancer Center Hospital East, Kashiwa, Japan.
Hiroki NagaseLaboratory of Cancer Genetics, Chiba Cancer Center Research Institute, Chiba, Japan.
Takashi UnoDepartment of Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Hisahiro MatsubaraDepartment of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Chiba Cancer Center · JPChiba University · JPNational Cancer Center Hospital East · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiogenomics is a new field that provides clinically useful prognostic predictions by linking molecular characteristics such as the genetic aberrations of malignant tumors with medical images. The abnormal expression of serum microRNA-1246 (miR-1246) has been reported as a prognostic factor of esophageal squamous cell carcinoma (ESCC). To evaluate the power of the miR-1246 level predicted with radiogenomics techniques as a predictor of the prognosis of ESCC patients. The real miR-1246 expression (miR-1246

Indexed as

AdultAgedAged, 80 and overBiomarkers, TumorDisease-Free SurvivalEsophageal Squamous Cell CarcinomaFemaleGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateMaleMicroRNAsMiddle AgedPrognosisRadiographyBiomarkers, TumorMicroRNAsMIRN1246 microRNA, human

Identifiers

PMID32054931
PMCPMC7018689
OpenAlexW3006036530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.